Company Study of Hualan Biological Engineering Ltd., 2011 (002007.SZ)
  • Apr/2012
  • Hard Copy
  • USD $239
  • Pages:10
  • Single User License
    (PDF Unprintable)       
  • USD $199
  • Code:
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $479
  • Hard Copy + Single User License
  • USD $289
      
Hualan Biological Engineering Ltd., (hereinafter referred to as Hualan Biological) established in 1992, is a national key high-tech enterprise engaged in the R&D and production of blood products. It became the first Chinese blood product manufacturer being granted GMP Certificate in 1998.

Presently, plasma collecting stations of Hualan Biological numbered 13 ones, 4 of which are located in Guangxi, one in Guizhou, seven in Chongqing and one in Henan, with the annual plasma collecting volume each approximating 50 tons. All the other 12 ones are under regular operation expect one plasma collecting station in Chongqing under construction.

1 Profile
2 Operation
3 Blood Products
4 Hualan Biological starts vaccine WHO pre-authentication
Operating Revenue and Net Income of Hualan Biological Engineering Ltd, 2007-2011
Operating Revenue of Hualan Biological Engineering Ltd (by Sector), 2007- 2011
Gross Margin of Hualan Biological Engineering Ltd (by Product), 2007- 2011
Operating Revenue of Hualan Biological Engineering Ltd (by Region), 2007-2011
Distribution of Plasma Collection Stations of Hualan Biological Engineering Ltd, by Aug. 2011
Release Volume of Blood Products of Hualan Biological Engineering Ltd, 2007-Jul. 2011 (Unit: 1,000 bottles)
Proportion of Blood Products Release Volume of Hualan Biological Engineering Ltd, 2008-Jul.2011
Operating Revenue of Blood Products of Hualan Biological Engineering Ltd (by Product), 2007- 2010 (Unit: RMB mln)

China Blood Products Industry Report, 2010-2011

Recent years have seen fast-growing development of blood product industry in China, with the enterprises concerned numbering 33 which can produce 10-odd blood products including human albumin, human i...

China Vacuum Blood Collection Industry Report, 2014-2017

The vacuum blood collection system consisting of vacuum blood collection tubes, disposable blood collection needles, tourniquets, etc transfers human venous blood to closed containers and makes it int...

China Pharmaceutical Excipients Industry Report, 2014-2017

Pharmaceutical excipients refer to adjuvants and additives used for production of pharmaceuticals and compounding of prescriptions. In addition to active ingredients, pharmaceutical excipients are als...

China Recombinant Protein Drug Industry Report, 2014-2017

The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein dru...

China Heparin Industry Report, 2014-2017

As the world's major heparin API producer and exporter, China boasts enormous raw materials, which provides a strong support for the production of China’s heparin products. In 2013, the live pigs rais...

Global and China Monoclonal Antibody Industry Report, 2014-2019

Despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal antibody market size exceeded USD 80 billion in 2013, still one of biot...

Global and China DNA Sequencing Industry Research Report, 2014-2017

DNA sequencing is the process of reading nucleotide bases in a specific DNA molecule, that is to say determining the arrangement mode of adenine, thymine, cytosine, and guanine. It can be applied in a...

Global and China Stem Cell Industry Report, 2014-2017

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatmen...

China Human Vaccine Industry Report, 2014-2017

Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China’s human vaccine lot release volume grew by 4.9% from a year earlie...

China Blood Product Industry Report, 2014-2017

Plasma resource reserves and control are crucial to the development of blood products industry. Although the closure of 16 plasma collection stations in Guizhou in 2011 didn’t cause major disruption t...

China Animal Vaccine Industry Report, 2013-2016

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. Europe and the United States and other developed countries are the main ...

China Contract Research Organization (CRO) Industry Report, 2013-2016

China CRO industry has developed rapidly in recent years, registering a CAGR of 27.2% during 2007-2013, of which the market size reached RMB 36 billion in 2013, occupying 10% of global market share. ...

Global and China Biodegradable Plastics Industry Report, 2013-2016

Global biodegradable plastic production and demand have grown rapidly in recent years, and the capacity reached 1-1.5 million t/a in 2012-2013. Among dozens of biodegradable plastic varieties develope...

Global and China Industrial Enzyme Industry Report, 2014-2016

In 2007-2013, the global industrial enzyme market size grew at the CAGR of 5.7%, reaching USD4.04 billion in 2013, 1.4 times that in 2007. The global industrial enzyme market is monopolized by a small...

China Heparin Industry Report, 2013-2015

Since the small intestines of pigs (raw materials for production of heparin) in China are abundant (the pig slaughtering volume in China approximates 50% of globe’s total) and heparin APIs are gradual...

China Lactic Acid and Derivative Industry Report, 2013

China’s lactic acid capacity and output continued to grow at the respective CAGR of 22.7% and 28.7% in 2007-2011. But limited by market demand, the annual output of most vendors was below their design...

China Human Vaccine Industry Report, 2012-2015

In the wake of China's economic growth and enhanced disease prevention awareness, Chinese human vaccine market has been expanding. In 2012, Chinese human vaccine market valued RMB10.5 billion with the...

China Blood Product Industry Report, 2012-2015

Plasma is a key raw material of the blood product industry. In August 2011, China shut down 16 plasma stations in Guizhou, resulting in a decrease of 15% in the plasma volume of the year. However, due...

China Animal Vaccine Industry Report, 2012-2015

In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory immunization system. Be...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统